Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Product containing phenylephrine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Product containing hydrocodone (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Product containing chlorphenamine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Product containing phenylephrine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocodone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenylephrine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chlorphenamine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocodone bitartrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenylephrine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chlorphenamine maleate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Has manufactured dose form |
Liquide oral |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
Is a |
Chlorphenamine-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|